Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Skin Disease in Rheumatology Patients Should Prompt Collaboration with Dermatologists

Vanessa Caceres  |  Issue: March 2015  |  March 1, 2015

Topical Steroids

Rheumatologists are sometimes uncomfortable treating skin disease in their patients—but there’s inevitably a clinical situation in which a patient presents with a rash, and you think that a short course of topical steroids might help. You may be certain the rash is related to the patient’s condition or medications used for that condition, be it psoriasis, psoriatic arthritis, cutaneous lupus or dermatomyositis.

For example, when treating psoriatic arthritis, “Although systemic treatments can work in the skin, it’s not uncommon to have residual skin disease,” says dermatologist and rheumatologist Joseph F. Merola, MD, Brigham and Women’s Hospital, Harvard Medical School, Boston. “It’s great if the rheumatologist has some level of comfort with the appropriate use of topical steroids,” says Dr. Merola, who has instructed on the topic.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Perhaps the dermatologists in your area are extremely busy, or the patient does not want to be shuttled to different specialists. Or perhaps you want to offer the patient some relief while they wait to be seen by a local dermatologist.

Here’s some guidance on what to prescribe, possible side effects and when you should leave the diagnosis and treatment to a dermatologist.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

What to Use

Topical corticosteroids range in potency from 1 to 7. Over-the-counter topicals have a potency of 7, at the lowest possible range. The highest potency topicals have a 1 ranking.

Rheumatologists should get to know one mild, one moderate and one potent topical treatment, Dr. Merola advises. One online resource that may help is the Topical Steroids Potency Chart, published by the National Psoriasis Foundation.

There are three specific steroids that dermatologist Ellen Frankel, MD, Rejuviderm MediSpa, Cranston, R.I., feels comfortable with nondermatologists prescribing: desonide (class 6), triamcinolone (class 4) or a short burst of clobetasol, which is a more potent therapy (class 1). A report in the January 2015 issue of Dermatologic Clinics focusing on topical therapies for psoriasis reported that clobetasol spray allows patients to apply steroids in areas that may be difficult to reach and may be more potent than the ointment formulation.1 Additionally, clobetasol propionate and betamethasone valerate in foam formulations dry rapidly, with little residue left on the skin.1

Topical steroids range in formulation from gels to liquids to ointments, the latter being the strongest, says Kate Ross, MD, LA Plastic Surgery and Dermatology, Bradenton, Fla. Each formulation has its advantages, depending on where it is used on the body, greasiness and ease of application, according to a paper on topical corticosteroids coauthored by Dr. Ross.2

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsPractice Support Tagged with:Dermatologyrheumatologistskin diseaseSteroidTreatment

Related Articles

    7 Tips That Dermatologists Want Rheumatologists to Know

    November 2, 2014

    Recommendations on diagnosing, treating health conditions that cross over both specialties

    What Rheumatologists Wish Their Colleagues Knew: Managing Skin Disease & Comorbidities

    March 3, 2017

    From treating rashes to uncovering a case of osteoarthritis, dermatologists and rheumatologists can work together in a variety of ways to improve patient care, says Joseph F. Merola, MD, MMSc…

    Challenges in Psoriatic Arthritis

    November 29, 2022

    PHILADELPHIA—Despite a large and ever-growing number of therapeutic options for our patients with psoriatic disease, it is not uncommon for us come across scenarios in which a patient’s response to therapy does not match our expectations and our shared goals for treatment. We all have those patients—the ones whose joints improve with one drug, but…

    2015 ACR/ARHP Annual Meeting: Skin Issues in Rheumatic Diseases Present Challenges

    March 15, 2016

    SAN FRANCISCO—A 40-year-old woman shows up in the clinic with scarring alopecia, with an area of hyperpigmentation on the rim of her scalp, extending from just behind the temple to behind her ears. An examination with a dermatoscope shows hyperkeratotic follicular plugging. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEThe case—in this example, the discoid form of cutaneous…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences